Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,961.00
Bid: 1,957.00
Ask: 1,959.00
Change: -39.00 (-1.95%)
Spread: 2.00 (0.102%)
Open: 2,008.00
High: 2,012.00
Low: 1,958.00
Prev. Close: 2,000.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Bernstein Raises ITV And Sky To Outperform

Tue, 13th Jan 2015 09:56

LONDON (Alliance News) - The following UK shares received analyst recommendations Tuesday morning and Mondays
----------
FTSE 100
----------
BERNSTEIN RAISES ITV TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 250 (220) PENCE
----------
BERNSTEIN RAISES SKY TO 'OUTPERFORM' ('MARKET-PERFORM') - TARGET 1050 (900) PENCE
----------
S&P CAPITAL IQ CUTS SHIRE TO 'BUY' ('STRONG BUY') - TARGET 5350 (4700) PENCE
----------
UBS RAISES BURBERRY PRICE TARGET TO 1650 (1510) PENCE - 'NEUTRAL'
----------
Investec Lifts BAE Systems Price Target to 440P From 430P, Keeps Sell
----------
Investec Raises Meggitt Price Target To 560P From 540P, Keeps At Buy
----------
UBS RAISES MEGGITT PRICE TARGET TO 510 (490) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE RAISES GKN PRICE TARGET TO 410 (380) PENCE - 'OUTPERFORM'
----------
JPMORGAN RAISES TESCO PRICE TARGET TO 185 (145) PENCE - 'UNDERWEIGHT'
----------
EXANE BNP CUTS CENTRICA PRICE TARGET TO 275 (330) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES VODAFONE PRICE TARGET TO 285 (280) PENCE - 'BUY'
----------
JEFFERIES INITIATES TULLOW OIL WITH 'UNDERPERFORM' - TARGET 345 PENCE
----------
BARCLAYS REINITIATES LONDON STOCK EXCHANGE LSE WITH 'OVERWEIGHT'
----------
BARCLAYS PUTS LONDON STOCK EXCHANGE LSE AUF 2550 PENCE
----------
CREDIT SUISSE RAISES ANTOFAGASTA TO 'NEUTRAL' ('UNDERPERFORM')
----------
BARCLAYS RAISES TAYLOR WIMPEY PRICE TARGET TO 147,6 (142,6) P - 'OVERWEIGHT'
----------
BERNSTEIN CUTS CENTRICA PRICE TARGET TO 270 (290) PENCE - 'MARKET-PERFORM'
----------
BERNSTEIN RAISES SEVERN TRENT TO 'OUTPERFORM' ('MARKET-PERFORM') - TP 2250 (1910) PENCE
----------
BERNSTEIN RAISES UNITED UTILITIES PRICE TARGET TO 1010 (980) P - 'OUTPERFORM'
----------
BERNSTEIN RAISES NATIONAL GRID PRICE TARGET TO 1010 (960) PENCE - 'OUTPERFORM'
----------
BERNSTEIN RAISES SSE PRICE TARGET TO 1450 (1330) PENCE - 'UNDERPERFORM'
----------
Liberum Raises Reed Elsevier Price Target To 1,300P, Rates At Buy
----------
Cantor Fitzgerald Raises WM Morrison Price Target To 200P, Keeps Buy
----------
JEFFERIES RAISES IAG PRICE TARGET TO 570 (480) PENCE - 'BUY'
----------
JEFFERIES RAISES EASYJET PRICE TARGET TO 1850 (1750) PENCE - 'BUY'
----------
FTSE 250
----------
JPMORGAN RAISES LAIRD PRICE TARGET TO 363 (318) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS RESTAURANT GROUP PRICE TARGET TO 730 (745) PENCE - 'OVERWEIGHT'
----------
SHORE CAPITAL INITIATES MAN GROUP WITH 'BUY'
----------
GOLDMAN RAISES MAN GROUP PRICE TARGET TO 185 (125) PENCE - 'NEUTRAL'
----------
SHORE CAPITAL INITIATES HENDERSON GROUP PLC WITH 'BUY'
----------
SHORE CAPITAL INITIATES JUPITER FUND WITH 'SELL'
----------
DAVY CUTS CENTAMIN PRICE TARGET TO 74 (77) PENCE - 'OUTPERFORM'
----------
NUMIS CUTS AVEVA GROUP PRICE TARGET TO 1740 (1810) PENCE - 'BUY'
----------
UBS RAISES TATE & LYLE TO 'BUY' ('NEUTRAL') - PRICE TARGET 680 (615) PENCE
----------
UBS RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 2700 (2200) PENCE - 'BUY'
----------
UBS CUTS AFREN PRICE TARGET TO 32 (55) PENCE - 'NEUTRAL'
----------
GOLDMAN RAISES CABLE & WIRELESS PRICE TARGET TO 70 (68) PENCE - 'BUY'
----------
GOLDMAN RAISES TALK TALK TELECOM PRICE TARGET TO 474,40 (419) PENCE - 'NEUTRAL'
----------
LIBERUM CUTS COBHAM TO 'HOLD' ('BUY') - TARGET 330 PENCE
----------
CREDIT SUISSE CUTS KAZ MINERALS TO 'UNDERPERFORM' ('NEUTRAL')
----------
BARCLAYS CUTS GREENE KING PRICE TARGET TO 835 (900) PENCE - 'EQUAL WEIGHT'
----------
BARCLAYS RAISES HOMESERVE PRICE TARGET TO 223 (211) PENCE - 'UNDERWEIGHT'
----------
TRADERS: NUMIS CUTS CINEWORLD TO 'HOLD' ('ADD') - TARGET 420 PENCE
----------
BERNSTEIN RAISES DRAX TO 'OUTPERFORM' ('UNDERPERFORM') - TARGET 420 (550) PENCE
----------
Cantor Fitzgerald Raises Debenhams Price Target To 70P, Keeps At Hold
----------
Investec Cuts Debenhams To Sell From Hold, Price Target 66p
----------
MAIN MARKET AND AIM
----------
JPMORGAN CUTS LAMPRELL PRICE TARGET TO 154 (180) PENCE - 'OVERWEIGHT'
----------
PANMURE CUTS BORDERS & SOUTHERN PETROLEUM PRICE TARGET TO 40 (50) PENCE - 'BUY'
----------
PANMURE CUTS FAROE PETROLEUM PRICE TARGET TO 180 (200) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2022 10:31

TOP NEWS: Hikma Pharmaceutical records revenue growth and lifts payout

(Alliance News) - Hikma Pharmaceutical PLC on Thursday reported full-year revenue growth on a "strong" performance by its three business segments and lifted its shareholder payout.

Read more
24 Feb 2022 07:58

Hikma Pharmaceutical delivers year of 'solid growth' and 'strategic momentum'

(Sharecast News) - Drugmaker Hikma Pharmaceutical said on Thursday that it had delivered another successful year of "solid growth and continued strategic momentum", with both revenue and operating profits improving year-on-year.

Read more
24 Feb 2022 07:50

LONDON MARKET PRE-OPEN: Share buybacks for Lloyds Banking and Hikma

(Alliance News) - Stock prices in London are seen opening sharply lower, with the FTSE 100 called down almost 200 points, amid fear of a full-scale war in eastern Europe after Russia announced the beginning of a military operation in Ukraine.

Read more
17 Feb 2022 16:08

UK earnings, trading statements calendar - next 7 days

Friday 18 February  
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
TBC Bank Group PLCFull Year Results
Monday 21 February 
Bank of Cyprus Holdings PLCFull Year Results
Dechra Pharmaceuticals PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Tristel PLCTrading Statement
Wilmington PLCHalf Year Results
Tuesday 22 February 
Antofagasta PLCFull Year Results
Bank of Georgia Group PLCFull Year Results
Benchmark Holdings PLCQ1 Results
Blancco Technology Group PLCHalf Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Coca-Cola HBC AGFull Year Results
Hargreaves Lansdown PLCHalf Year Results
HSBC Holdings PLCFull Year Results (at 0400 GMT)
InterContinental Hotels Group PLCFull Year Results
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Synectics PLCFull Year Results
Transense Technologies PLCHalf Year Results
Wednesday 23 February 
Aston Martin Lagonda Global Holdings PLCFull Year Results
Barclays PLCFull Year Results
Capital & Counties Properties PLCFull Year Results
CAP-XX LtdHalf Year Results
Georgia Capital PLCFull Year Results
International Personal Finance PLCFull Year Results
Irish Residential Properties REIT PLCFull Year Results
Metro Bank PLCFull Year Results
Hochschild Mining PLCFull Year Results
Photo-Me International PLCFull Year Results
Rio Tinto PLCFull Year Results
Seraphim Space Investment Trust PLCHalf Year Results
Ted Baker PLCTrading Statement
Unite Group PLCFull Year Results
Thursday 24 February 
Anglo American PLCFull Year Results
BAE Systems PLCFull Year Results
Centrica PLCFull Year Results
Conduit Holdings LtdFull Year Results
Derwent London PLCFull Year Results
Drax Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Inchcape PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Rathbone Group PLCFull Year Results
Ricardo PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
St James's Place PLCFull Year Results
Tremor International LtdFull Year Results
WPP PLCFull Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
9 Feb 2022 09:48

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

LONDON BROKER RATINGS: Barclays downgrades Chemring and boohoo

Read more
3 Feb 2022 09:12

Hikma completes acquisition of Teligent's Canadian assets

Hikma completes acquisition of Teligent's Canadian assets

Read more
17 Jan 2022 09:01

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 09:00

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

TOP NEWS: Hikma Pharmaceutical acquires Teligent for USD45.8 million

Read more
17 Jan 2022 07:49

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

LONDON MARKET PRE-OPEN: Unilever sees good fit in GSK Consumer Health

Read more
17 Jan 2022 07:08

Hikma buys Teligent Canadian assets for $47.75m

(Sharecast News) - Hikma Pharmaceuticals on Monday said it had agreed to buy the Canadian assets of Teligent for $45.75m after the US firm filed for Chapter 11 bankruptcy last year.

Read more
10 Jan 2022 07:44

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

LONDON MARKET PRE-OPEN: Plus500 hails 2021 and mulls new share buyback

Read more
10 Jan 2022 07:24

Hikma launches new US injectables unit

(Sharecast News) - Hikma Pharmaceuticals on Monday said it was expanding its injectables business with the launch of a new outsourced sterile compounding business in the US.

Read more
21 Dec 2021 15:55

Arecor flags milestone payment from Hikma in first half of next year

(Sharecast News) - Biopharmaceutical company Arecor Therapeutics updated the market on its ongoing exclusive agreement with Hikma Pharmaceuticals to co-develop a new, ready-to-use injectable medicine on Tuesday.

Read more
9 Dec 2021 09:25

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Hikma adds two biosimilars to portfolio with Gedeon Richter agreement

Read more
9 Dec 2021 08:32

Hikma strikes exclusive license agreement with Richter for denosumab

(Sharecast News) - Drugmaker Hikma Pharmaceuticals has entered into an exclusive license agreement with Gedeon Richter to commercialise the latter's denosumab products in the US.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.